Cas:157652-31-8 3,4-Difluoro-2-methylbenzoic acid manufacturer & supplier

We serve Chemical Name:3,4-Difluoro-2-methylbenzoic acid CAS:157652-31-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-Difluoro-2-methylbenzoic acid

Chemical Name:3,4-Difluoro-2-methylbenzoic acid
CAS.NO:157652-31-8
Synonyms:3,4-Difluoro-2-methylbenzoic acid;QVR CF DF B1;3,4-Difluoro-o-toluic acid;Benzoic acid, 3,4-difluoro-2-methyl-
Molecular Formula:C8H6F2O2
Molecular Weight:172.129
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:268.0±35.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.512
PSA:37.30000
Exact Mass:172.033585
LogP:2.71

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3,4-Difluoro-2-methylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzoic acid, 3,4-difluoro-2-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid, 3,4-difluoro-2-methyl- Use and application,3,4-Difluoro-2-methylbenzoic acid technical grade,usp/ep/jp grade.


Related News: With its offering of API development, GMP manufacturing, solid state chemistry and analytical expertise, Onyx continues to experience strong growth driven by demand from biotech and pharmaceutical companies for its integrated CMC capabilities. tributylstannyl 2-tosylacetate manufacturers This commercial API license is incredibly important as it marks the next phase in our growth and enables us to support customers from concept to commercialization. We are now able to fill the gap in the market for small-scale commercial API requirements while maintaining our expertise in delivering early-stage programs.” 2,2,7-Trimethyl-3,3a,5,6-tetrahydro-2H-indene-1,4-dione suppliers The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. N-(4-(tert-butyl)phenyl)-4-(3,5-diethyl-1H-pyrazol-1-yl)benzamide vendor & factory.